Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 28

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 28
---
 price, were outstanding under our option
and incentive plans, and options to purchase 338,634 ordinary shares were exercisable and 32,685 RSUs were vested. An additional 88,326
ordinary shares remained available for future grant under our 2021 Plan as of that date.

Among other types of equity-based awards, our share option and
incentive plans provide for granting awards in compliance with Section 102 of the Israeli Income Tax Ordinance [New Version], 5721-1961,
or the Tax Ordinance, which provides to employees, directors and officers, who are not controlling shareholders ( i. e.,
who hold less than 10% of our share capital) and are Israeli residents, favorable tax treatment for compensation in the form of shares,
options, RSUs or other types of equity awards issued or granted, as applicable, to a trustee under the “capital gains track”
for the benefit of the relevant employee, director or officer and are held by the trustee for at least two years after the date of grant
or issuance. Under the “capital gains track”, we are not allowed to deduct an expense with respect to the grant or issuance
of the relevant equity-based awards.

The 2021 Plan also permits us to grant equity-based awards to
U. S. residents, in accordance with the applicable provisions of the U. S. Internal Revenue Code of 1986, as amended, or the Code.

Awards granted under our plans may be subject to vesting schedules.
Options to purchase our ordinary shares granted under our plans expire 10 years from the grant date. The plans address the treatment of
vested and unvested awards upon the termination of employment of the award holder as well as upon consummation of a merger or consolidation
of our company, or sale of all or substantially all of our shares or assets.

Subsidiary Equity Incentive
Plans

In addition to the share option and incentive plans at our parent
company level, each of our subsidiaries has adopted its own equity incentive plan. The following table presents information regarding
our subsidiaries’ equity incentive plans, including the percentage of the equity of those companies that may be issued or granted
as equity incentives to employees, directors or service providers of those companies and the percentage of that equity that has been issued
or granted as of March 17, 2025 (in both cases, after including shares underlying options).

  Subsidiary      Percentage of Subsidiary's Equity Issuable as